Inventor
Mark Holoboski
Inventor
Laguna Niguel, CA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes25%
C07DHeterocyclic compounds23%
C07CAcyclic or carbocyclic compounds14%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
A47GHousehold or table equipment3%
PatentTitleYear
9,765,065'Therapeutic substituted cyclopentanes'20179,591,935'Therapeutic substituted cyclopentanes'20178,487,091'Substituted cyclopentanes having prostaglandin activity'20138,193,373'Therapeutic compounds'20127,964,634'Therapeutic compounds'20117,960,378'Therapeutic compounds'20117,872,045'Combination therapy for glaucoma treatment'20117,612,082'Prostaglandin EP4 antagonists'20097,514,462'ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists'20097,223,746'Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists'20077,183,324'2,3,4-substituted cyclopentanones as therapeutic agents'20077,022,726'ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists'20066,956,057'EP4 agonists as agents for lowering intraocular pressure'20056,767,920'3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure'20046,710,072'-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists'20046,586,462'-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists'20036,538,018'3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure'20036,410,591'3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure'20026,376,533'Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists'20026,359,181'Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents'20026,307,092'Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents'20016,248,783'Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2002Patents assigned to ALLERGAN SALES INC (5)· patent assignee history
2001–2011Based in Laguna Niguel, CA, US· patent location history
2003–2017Patents assigned to ALLERGAN INC (16)· patent assignee history
2011–2017Based in Irvine, CA, US· patent location history
2012–2017Patents assigned to HOLOBOSKI MARK (3)· patent assignee history
2012–2017Patents assigned to POSNER MARI (3)· patent assignee history
2012–2013Patents assigned to BURK ROBERT M (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALLERGAN INC | 16 | 2003–2017 |
| ALLERGAN SALES INC | 5 | 2001–2002 |
| HOLOBOSKI MARKself | 3 | 2012–2017 |
| POSNER MARI | 3 | 2012–2017 |
| BURK ROBERT M | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Laguna Niguel, California, US | 16 | 2001–2011 |
| Irvine, California, US | 6 | 2011–2017 |